Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from MedPal AI Plc ( (GB:MPAL) ) is now available.
MedPal AI Plc has announced a retail offer to raise up to £1,000,000 through the issuance of new ordinary shares at a discounted price. The funds will support the company’s strategy following its acquisition of assets from Universal Pharmacy Ltd, allowing it to enter the growing obesity treatment market. The offer is open to eligible UK investors and is expected to close on 1 October 2025, with trading commencing on AIM on 8 October 2025.
More about MedPal AI Plc
MedPal AI Plc operates in the digital health industry, focusing on health platforms. The company is positioning itself in the GLP-1 agonist market for obesity treatment, which includes drugs like semaglutide.
Average Trading Volume: 1,971,501
Find detailed analytics on MPAL stock on TipRanks’ Stock Analysis page.